News

Drug developers aren’t expected to come back to the US equity markets in full force until next year — lagging other ...
As the World Health Organization initiates a new agreement for coordinating global responses to future pandemics, the future ...
Ankyra Therapeutics is a biotech developing anchored immunotherapies aimed at enhancing the therapeutic window of ...
Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...
Three-quarters of US-based researchers and graduate students are considering working abroad, according to a recent study.
Biotechnology has emerged as a driving force in transforming healthcare. Over the past few decades, the integration of biology with advanced technology has led to significant breakthroughs. These ...
A BioSpace survey found that 56% of employed and 81% of unemployed respondents are considering jobs outside biopharma. Some ...
“April’s rise in inflation was widely expected, driven by a perfect storm of price pressures such as higher employer National ...
The global digital health market is undergoing a radical transformation—and nowhere is this more evident than in clinical trials. As of 2025, the demand for digital health solutions is projected to ...
ORI Capital is planning a US$350 million fund to focus on Chinese biotech, with hopes that AI will help beat the market.
McDermott was pleased to once again host our annual European Health & Life Sciences Symposium in Paris. Welcoming a crowd of more than ...
EnteroBiotix Presents Positive Data in Liver Cirrhosis at EASL 2025 EBX-102 was well tolerated and showed multiple positive trends over placeboFindings support progression to a Phase 2b trial Glasgow ...